1. Global tuberculosis report,2019
2. Trends in burden of multidrug-resistant tuberculosis in countries, regions, and worldwide from 1990 to 2017: results from the Global Burden of Disease study;Ou;Infect Dis Poverty,2021
3. Prevalence and factors associated with multidrug-resistant tuberculosis in South India;Shivekar;Sci Rep,2020
4. Ministry of Health and Family Welfare, HFW/Measures taken to reduce TB cases in India/16 december 2022/3, (release ID: 1884180) visitor counter:1748 posted on: 16 DEC 2022 5:22 PM by PIB Delhi https://www.pib.gov.in/PressReleasePage.aspx?PRID=1884180#:∼:text=Universal%20Drug%20Susceptibility%20Testing%20(UDST,time%20of%20treatment%20initiation%20itself. [accessed 9 August 2023].
5. rpoB mutations causing discordant rifampicin susceptibility in Mycobacterium tuberculosis: retrospective analysis of prevalence, phenotypic, genotypic, and treatment outcomes;Mvelase;Open Forum Infect Dis,2019